50 results Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Getting the Deal Through – Private M&A 2021: The Benelux chapters Getting The Deal Through works with many of the best lawyers and law firms in the world to bring together a unique legal information resource, written by experts on each subject area, in every significant jurisdiction. Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Les actions sans droit de vote et les parts bénéficiaires à l'ère du CSA Marc Fyon et Viktor Pokorny examinent et comparent le régime applicable aux actions sans droit de vote et aux parts bénéficiaires à l'ère du Code des sociétés et associations dans la Revue pratique des sociétés (RPS-TRV). Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby. Getting the Deal Through – Private M&A 2022: The BeNeLux chapters A team of Stibbe lawyers from our Brussels, Luxembourg and Amsterdam offices have authored the BeNeLux sections of the Private M&A 2022 chapters published by Lexology Getting the Deal Through. Digital Law Up(to)date: No processing of vaccination status in recruitment process The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Stibbe advises Alro Group Stibbe assisted the Thijs family and the management as selling shareholders in the Alro Group with the sale of a majority stake to Gimv. Stibbe advises MBK Partners Stibbe advised MBK Partners on the acquisition of Godiva. Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Stibbe advises Abry Partners and KORE Stibbe advised Abry Partners, a private equity fund, and its portfolio-company KORE, the independent global IoT leader, on the acquisition of ASPIDER-NGI, a leading provider of advanced connectivity, core network, and eSIM solutions. Webinar: SPACs from a Belgian perspective On 22 June 2021, Pascal Vanden Borre and Willem Witters host a webinar on SPAC's for the members of the Practice Group Corporate of IBJ/IJE. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Pagination Current page 1 Page 2 Page 3 Next page
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Getting the Deal Through – Private M&A 2021: The Benelux chapters Getting The Deal Through works with many of the best lawyers and law firms in the world to bring together a unique legal information resource, written by experts on each subject area, in every significant jurisdiction.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Les actions sans droit de vote et les parts bénéficiaires à l'ère du CSA Marc Fyon et Viktor Pokorny examinent et comparent le régime applicable aux actions sans droit de vote et aux parts bénéficiaires à l'ère du Code des sociétés et associations dans la Revue pratique des sociétés (RPS-TRV).
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby.
Getting the Deal Through – Private M&A 2022: The BeNeLux chapters A team of Stibbe lawyers from our Brussels, Luxembourg and Amsterdam offices have authored the BeNeLux sections of the Private M&A 2022 chapters published by Lexology Getting the Deal Through.
Digital Law Up(to)date: No processing of vaccination status in recruitment process The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Stibbe advises Alro Group Stibbe assisted the Thijs family and the management as selling shareholders in the Alro Group with the sale of a majority stake to Gimv.
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
Stibbe advises Abry Partners and KORE Stibbe advised Abry Partners, a private equity fund, and its portfolio-company KORE, the independent global IoT leader, on the acquisition of ASPIDER-NGI, a leading provider of advanced connectivity, core network, and eSIM solutions.
Webinar: SPACs from a Belgian perspective On 22 June 2021, Pascal Vanden Borre and Willem Witters host a webinar on SPAC's for the members of the Practice Group Corporate of IBJ/IJE.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.